BUDAPEST (Reuters) – Hungary has embarked on the approval process for the Sinopharm coronavirus vaccine developed by the company’s Beijing-based affiliate that got approved in China in December, the Hungarian foreign minister’s spokesman said on Thursday.
“The approval process … is under way …under guidance of Hungarian experts,” Tamas Menczer said in a reply to emailed questions from Reuters.
Hungary would be the first EU country to approve a Chinese vaccine.
(Reporting by Krisztina Than; editing by John Stonestreet)
